Power Law company profile

ViewRay

Biotech & Life Sciences · Oakwood, United States · Founded 2004 · IPO 2015 Thoroughbred

Advanced radiation therapy technology for the treatment of cancer

Valuation

$1K

Market cap · 2026

Revenue

$102M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

7 investors on ViewRay's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

N47

Aisling Capital

Centre for Genomic Regulation

OrbiMed

Fidelity Investments

Hercules Capital

F-Prime

Global footprint

Where ViewRay has talent and traffic

AI talent share

1.6% of workforce is AI talent
(1 of 64 staff)

Core AI00%

Other AI11.56%

Non-AI workforce6398.44%

Workforce by country

7 countries with
team presence

🇺🇸 United States76.2%

🇩🇪 Germany8.9%

🇹🇭 Thailand3%

🇧🇬 Bulgaria3%

🇨🇳 China3%

Top 5 of 7 shown

Web traffic by country

2.6K monthly visits
across markets

🇮🇳 India50%

🇺🇸 United States50%

Top 2 markets shown

Market sentiment

What the market is saying about ViewRay

An AI-synthesized read of the highest-engagement posts about ViewRay on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ViewRay on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles